SCHEMBL7339157

SCHEMBL7339157

CCOC(=O)C(Cc1ccc(Cl)c(Cl)c1)NC(=O)CNC(=O)c1cccc(NC=NN)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.44
GPR139 Q6DWJ6 6/20 0.41
CTSB P07858 3/20 0.40
KLKB1 P03952 1/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
CTSV O60911 2/20 0.37
CTSL P07711 2/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 2/20 0.37
MAPT P10636 2/20 0.37
ITGB1 P05556 2/20 0.37
ITGA5 P08648 2/20 0.37
EPHX2 P34913 1/20 0.37
TP53 P04637 1/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7341105 0.91 CTSL (0.46) GPR139CTSBMEN1KMT2AATM
SCHEMBL6778084 0.89 GPR139 (0.45) GPR139CTSBMEN1KMT2AATM
SCHEMBL7825718 0.89 TP53 (0.47) TACR1GPR139MEN1KMT2AITGB1
SCHEMBL7340345 0.88 TP53 (0.39) GPR139ITGB1ITGA5TP53NPC1
SCHEMBL7341748 0.88 TACR1 (0.41) TACR1GPR139MEN1KMT2AITGB1
SCHEMBL7344058 0.87 GLA (0.41) CTSBMEN1KMT2ACTSLCTSS
SCHEMBL7338364 0.85 GPR139 (0.45) GPR139SMN1; SMN2MEN1KMT2ACTSL
SCHEMBL7339503 0.85 KMT2A (0.42) GPR139SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7825264 0.85 HSD17B10 (0.47) TSHRSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7344119 0.85 GPR139 (0.38) GPR139MEN1KMT2AATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP disclosed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO disclosed